Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6NHA

Crystal structure of SYNT001, a human FcRn blocking monoclonal antibody

Summary for 6NHA
Entry DOI10.2210/pdb6nha/pdb
DescriptorIgG receptor FcRn large subunit p51, Beta-2-microglobulin, SYNT001-Fab light chain, ... (6 entities in total)
Functional Keywordsfcrn, b2m, circulating igg and igg immune complex, synt001, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight90404.19
Authors
Blumberg, R.S.,Cheung, J.,Mahmood, A.,Gandhi, A.K. (deposition date: 2018-12-21, release date: 2019-12-25, Last modification date: 2024-11-06)
Primary citationBlumberg, L.J.,Humphries, J.E.,Jones, S.D.,Pearce, L.B.,Holgate, R.,Hearn, A.,Cheung, J.,Mahmood, A.,Del Tito, B.,Graydon, J.S.,Stolz, L.E.,Bitonti, A.,Purohit, S.,de Graaf, D.,Kacena, K.,Andersen, J.T.,Christianson, G.J.,Roopenian, D.C.,Hubbard, J.J.,Gandhi, A.K.,Lasseter, K.,Pyzik, M.,Blumberg, R.S.
Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses.
Sci Adv, 5:eaax9586-eaax9586, 2019
Cited by
PubMed Abstract: The neonatal crystallizable fragment receptor (FcRn) functions as an intracellular protection receptor for immunoglobulin G (IgG). Recently, several clinical studies have reported the lowering of circulating monomeric IgG levels through FcRn blockade for the potential treatment of autoimmune diseases. Many autoimmune diseases, however, are derived from the effects of IgG immune complexes (ICs). We generated, characterized, and assessed the effects of SYNT001, a FcRn-blocking monoclonal antibody, in mice, nonhuman primates (NHPs), and humans. SYNT001 decreased all IgG subtypes and IgG ICs in the circulation of humans, as we show in a first-in-human phase 1, single ascending dose study. In addition, IgG IC induction of inflammatory pathways was dependent on FcRn and inhibited by SYNT001. These studies expand the role of FcRn in humans by showing that it controls not only IgG protection from catabolism but also inflammatory pathways associated with IgG ICs involved in a variety of autoimmune diseases.
PubMed: 31897428
DOI: 10.1126/sciadv.aax9586
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.381 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon